There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
Ranbaxy Laboratories Ltd has degrown for the month and ranks sixth. Cipla Ltd has been showing consistent improvement month-on-month (m-o-m). Cadila Healthcare Ltd has had a positive turnaround and even Unichem Laboratories Ltd’s performance inched up...
Five Star Equities examines the outlook for companies in the Drug Manufacturers - Major Industry and provides equity research on Pfizer, Inc. (NYSE: PFE) and GlaxoSmithKline Plc (NYSE: GSK) (LSE: GSK). Access to the full company reports can be found...
A left-wing activist throws a bottle past the gates of British drugmaker GlaxoSmithKline Laboratories in Buenos Aires February 16, 2012. Long-standing diplomatic tensions over the Falkland islands have bubbled up in recent months in the run-up to the... View Photo »
world's largest research-ba... The world of electronic medical records is very secretive. Vendors will not allow their programs or data structures to be examined, even... We have posted multiple times about Avandia (rosiglitazone), GlaxoSmithKline's star-crossed glucose-lowering drug. While Avandia has ...
Post your opinion here PINC Research is bearish on GlaxoSmithKline Pharmaceuticals (GSK Pharma) and has recommended sell rating on the stock with a target price of Rs 1880 in its February 16, 2012 research report. "GSK Pharma's Q4CY11 results were...
The Fairmount Park Conservancy, the primary private-sector fund-raiser for Fairmount Park, has appointed Daniel Phelan to its board. Phelan is the senior adviser to the chief executive officer at GlaxoSmithKline P.L.C. The Philadelphia Chapter of...
Generally, the higher these numbers, the better. That said, too much debt can sink a company, so beware of companies with very high leverage ratios. So what does the DuPont Formula say about these four companies? GlaxoSmithKline offers very high...
A left-wing activist sets fire on a British flag during a demonstration outside British drugmaker GlaxoSmithKline Laboratories in Buenos Aires February 16, 2012. Long-standing diplomatic tensions over the Falkland islands have bubbled up in recent... View Photo »
We are grateful to Pfizer for their funding and their innovation in issuing a ‘challenge’ for others to fund the research, which is outside of the ‘normal’ scope of most commercial support of CME. We are thrilled that Glaxo Smith Kline and Lilly & Co have provided the needed funds to complete the resear...
Minister of Health Zhu Chen, who was speaking to reporters at a World Health Organization briefing. Although the 2009 list was made up of basic products, mainly generics, Chen said the revised formulary may include patent-protected drugs for specialized...
Glaxo Smith Kline denies the charges and says it will appeal the nearly $240,000 fine imposed on the company and two doctors. According to CNN ii : "The deaths of 14 children, who reportedly died after participating in the trials, have drawn widespread...
There are no results for this module. Edit this module to change the search term used to query Wikipedia
A left-wing activist sets fire on a British flag during a demonstration outside British drugmaker GlaxoSmithKline Laboratories in Buenos Aires February 16, 2012. Long-standing diplomatic tensions over the Falkland islands have bubbled up in recent months in the run-up to the 30th...
View Photo »Workers try to put out fire at the gates of British drugmaker GlaxoSmithKline Laboratories headquarters during a protest by left-wing demonstrators in Buenos Aires February 16, 2012. Long-standing diplomatic tensions over the Falkland islands have bubbled up in recent months in the...
View Photo »Microsoft founder Bill Gates (R) speaks at the "Uniting to Combat Neglected Tropical Diseases" conference as GlaxoSmithKline Chief Executive Officer Andrew Witty looks on at the Royal College of Physicians in London January 30, 2012.
View Photo »Picture syringe on a vaccine production line taken on December 16, 2011 at the new plant of U.K.'s largest drug maker GlaxoSmithKline (GSK) in Saint-Amand-les-Eaux, northern France, one day after its inauguration.
View Photo »Picture of the new plant of U.K.'s largest drug maker GlaxoSmithKline (GSK) taken on December 16, 2011 in Saint-Amand-les-Eaux, northern France, one day after its inauguration.
View Photo »A man is at work at a vaccine production line, on December 16, 2011 at the new plant of U.K.'s largest drug maker GlaxoSmithKline (GSK) in Saint-Amand-les-Eaux, northern France, one day after its inauguration.
View Photo »The groundbreaking ceremony for the new GlaxoSmithKline (GSK) Building at Philadelphia's Navy Yard Corporate Center included a tree planting ceremony that underscored developers Liberty Property Trust and Synterra Partners as well as GSK's commitment to sustainability. Planting three...
View Photo »In a file picture taken on July 13, 2011 News International Chairman and Chief Executive James Murdoch arrives for work in east London. James Murdoch, at the centre of the phone hacking scandal in his family's British newspaper business, has resigned from the board of GlaxoSmithKline,...
View Photo »Scientist Joe Cohen is seen posing for a photograph at GlaxoSmithKline biologicals (GSK) research site in Rixensart, Belgium in this December 8, 2010 file photograph. For Joe Cohen, a GlaxoSmithKline research scientist who has spent 24 years trying to create the world's first malaria...
View Photo »BERLIN, GERMANY - OCTOBER 12: People walk past a building that houses offices of pharmaceutical giant GlaxoSmithKline, aluminum producer Trimet and Deutsche Boerse on Unter den Linden avenue in Mitte district on October 12, 2011 in Berlin, Germany. Mitte district is home not only to...
View Photo »Blood samples are pictured at the Swiss Laboratory for Doping Analysis in Epalinges near Lausanne in this July 15, 2008 file photo. The battle to keep drugs out of the London Olympics has started long before the opening ceremony next July. A sophisticated laboratory provided by...
View Photo »British Telecoms public telephone boxes are pictured in central London, on November 13, 2008. British telecoms operator BT Group said Thursday it will cut 10,000 jobs by March 2009 despite soaring profits, becoming the latest company to wield the axe as recession looms in Britain. ...
View Photo »Chief Business Officer of Dutch-based biotech Prosensa Luc Dochez speaks during an interview in Leiden February 10, 2011. Prosensa is one of a new wave of successful biotechs that are emerging, many of them in the Benelux and Scandinavia, and stepping over a past generation of biotech...
View Photo »CEO of Dutch-based biotech Prosensa, Hans Schikan talks during an interview in Leiden February 10, 2011. Prosensa is one of a new wave of successful biotechs that are emerging, many of them in the Benelux and Scandinavia, and stepping over a past generation of biotech casualties. The...
View Photo »Dutch-based biotech firm Prosensa's researchers work on developing, possibly the world's first treatment for Duchenne muscular dystrophy disease (DMD), at their new laboratory in Leiden February 17, 2011. Prosensa is one of a new wave of successful biotechs that are emerging, many of...
View Photo »A left-wing activist sets fire on a British flag during a demonstration outside British drugmaker GlaxoSmithKline Laboratories in Buenos Aires February 16, 2012. Long-standing diplomatic tensions over the Falkland islands have bubbled up in recent months in the run-up to the 30th...
View Photo »world's largest research-ba... The world of electronic medical records is very secretive. Vendors will not allow their programs or data structures to be examined, even... We have posted multiple times about Avandia (rosiglitazone), GlaxoSmithKline's star-crossed glucose-lowering drug. While Avandia has ...
We are grateful to Pfizer for their funding and their innovation in issuing a ‘challenge’ for others to fund the research, which is outside of the ‘normal’ scope of most commercial support of CME. We are thrilled that Glaxo Smith Kline and Lilly & Co have provided the needed funds to complete the resear...
He has been in large cap defensives such as GlaxoSmithKline and Imperial Tobacco since August, whereas the market is down 20pc
